JTL
CPRX

Jupiter Topco LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Jupiter Topco LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.6M Buy
+2,277,822
New +$67.2M 0.03% 374

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco LLC's CPRX Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 2,277,822 shares worth $71.6M. The stake represents 0.03% of the portfolio and ranks #374 among its holdings.

370 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Jupiter Topco LLC held 2,277,822 shares of Catalyst Pharmaceutical worth $71.6M as of Q2 2026.
  • Catalyst Pharmaceutical was a new Jupiter Topco LLC position in Q2 2026.
  • Catalyst Pharmaceutical made up 0.03% of Jupiter Topco LLC's portfolio in Q2 2026, its #374 holding.
  • 370 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.